What is CRISPR Therapeutics AG's Market Cap?

CRISPR Therapeutics AG's Market Cap is $5.2B, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Enterprise Value?

CRISPR Therapeutics AG's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Price / Sales?

CRISPR Therapeutics AG's Price / Sales is 388.7×, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EV / Revenue?

CRISPR Therapeutics AG's EV / Revenue is 256.7×, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EV / EBITDA?

CRISPR Therapeutics AG's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Revenue (TTM)?

CRISPR Therapeutics AG's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Net Income (TTM)?

CRISPR Therapeutics AG's Net Income (TTM) is -$451.1M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EBITDA?

CRISPR Therapeutics AG's EBITDA is -$515.6M, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's Diluted EPS (TTM)?

CRISPR Therapeutics AG's Diluted EPS (TTM) is -4.67, based on as-reported figures from SEC (XBRL) filings.

What is CRISPR Therapeutics AG's EBITDA Margin?

CRISPR Therapeutics AG's EBITDA Margin is -3850.4%, based on as-reported figures from SEC (XBRL) filings.

CRISPR Therapeutics AG (CRSP) Financial Statements

CRISPR Therapeutics AG

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00DBBGRY0

XNAS · usd

53.84▼ 0.94 (-1.72%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close54.78

Day's Range52.78 – 55.10

52-Week Range44.12 – 78.48

Volume1.4M

Avg Volume1.4M

Share Statistics

Shares Outstanding

Employees393

ExchangeXNAS

Listed2016-10-19

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about CRISPR Therapeutics AG (CRSP)

What is CRISPR Therapeutics AG's Market Cap?: CRISPR Therapeutics AG's Market Cap is $5.2B, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Enterprise Value?: CRISPR Therapeutics AG's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Price / Sales?: CRISPR Therapeutics AG's Price / Sales is 388.7×, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EV / Revenue?: CRISPR Therapeutics AG's EV / Revenue is 256.7×, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EV / EBITDA?: CRISPR Therapeutics AG's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Revenue (TTM)?: CRISPR Therapeutics AG's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Net Income (TTM)?: CRISPR Therapeutics AG's Net Income (TTM) is -$451.1M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EBITDA?: CRISPR Therapeutics AG's EBITDA is -$515.6M, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's Diluted EPS (TTM)?: CRISPR Therapeutics AG's Diluted EPS (TTM) is -4.67, based on as-reported figures from SEC (XBRL) filings.
What is CRISPR Therapeutics AG's EBITDA Margin?: CRISPR Therapeutics AG's EBITDA Margin is -3850.4%, based on as-reported figures from SEC (XBRL) filings.